Prognostic significance of cyclin A expression in meningiomas

Applied Immunohistochemistry and Molecular Morphology

Volumn 11, Issue 1, 2003, Pages 9-14

  Nakabayashi, Hiromichi ^a   Shimizu, Keiji ^a   Hara, Mitsuhiro ^b  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

BrdU; Cyclin A; Ki 67; Meningioma; Proliferation

Indexed keywords

BROXURIDINE; CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER GRADING; CELL CYCLE; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; TUMOR RECURRENCE;

EID: 0037347895     PISSN: 15412016     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129039-200303000-00002     Document Type: Article

References (36)

1. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-7.
2. Pines J, Hunter T. Cyclin A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J Cell Biol 1991;115:1-17.
3. Peterlini P, Suberville AM, Zindy F, et al. Cyclin A expression in human hematological malignancies: a new marker of cell proliferation. Cancer Res 1993;53:235-8.
4. Volm M, Koomägi R, Mattern J, et al. Cyclin A is associated with an unfavorable outcome in patients with non-small cell lung carcinomas. Br J Cancer 1997;75:1774-8.
5. Shinozawa T, Xin L, Nikaido T, et al. Immunohistochemical detection of cyclin A with reference to p53 expression in endometrial endometrioid carcinomas. Int Gyneco Pathol 1997;16:348-53.
6. Allan K, Jordan RC, Ang LC, et al. Overexpression of cyclin A and cyclin B1 proteins in astrocytomas. Arch Pathol Lab Med 2000; 124:216-20.
7. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957;20:22-39.
8. Kleihues P, Cavenee WK, eds. World Health Organization classification of tumours: pathology and genetics of tumours of the nervous system. Lyon: IARC Press, 2000.
9. Handa K, Yamakawa M, Takeda H, et al. Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis. Int J Cancer 1999;84:225-33.
10. Huuhtanen RL, Blomqvist CP, Bohling TO, et al. Expression of cyclin A in soft tissue sarcoma correlates with tumor aggressiveness. Cancer Res 1999;59:2885-90.
11. Chakrabarty A, Bridges LR. Immunohistochemical analysis of cyclin A in astrocytic tumours. Neuropathol Appl Neurobiol 1998; 24:239-45.
12. Dirks PB, Hubbard SL, Murakami M, et al. Cyclin and cyclin-dependent kinase expression in human astrocytoma cell lines. J Neuropathol Exp Neurol 1997;56:291-300.
13. Kakino S, Sasaki K, Kurose A, et al. Intracellular localization of cyclin B1 during the cell cycle in glioma cells. Cytometry 1996; 24:49-54.
14. Numa Y, Tsukazaki Y, Yamamoto M, et al. Cyclin A protein expression on malignant glioma cells. Hum Cell 1998;111:21-6.
15. Ren Y, Munyer P, Kepes JJ, et al. Comparison of cyclin A and MIB-1 expression in astrocytic tumors using image-based cell analysis system. Appl Immunohistochem Mol Morphol 2001;9:14-8.
16. Christensen D, Laursen H, Klinken L. Prediction of recurrence in meningiomas after surgical treatment. A quantitative approach. Acta Neuropathol 1983;61:130-4.
17. Marks SM, Whitwell HL, Lye RH. Recurrence of meningiomas after operation. Surg Neurol 1986;25:436-40.
18. Mirimanoff RO, Dosoretz DE, Linggood RM, et al. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985;62:18-24.
19. Hoshino T, Nagashima T, Murovic JA, et al. Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine. Cancer 1986;58:1466-72.
20. Lee KS, Hoshino T, Rodriguez LA, et al. Bromodeoxyuridine labeling study of intracranial meningiomas: Proliferative potential and recurrence. Acta Neuropathol 1990;80:311-7.
21. Ironside JW, Battersby RDE, Lawry J, et al. DNA in meningioma tissues and explant cell cultures. A flow cytometric study with clinico-pathological correlates. Neurosurg 1987;66:588-94.
22. May PL, Broome JC, Lawry J, et al. The prediction of recurrence in meningiomas: A flow cytometric study of paraffin-embedded archival materials. J Neurosurg 1987:71:347-51.
23. Cobb MA, Husain M, Andersen BJ, et al. Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningiomas. J Neurosurg 1996;84:85-90.
24. Hsu DW, Prado FS, Efird JT, et al. Prognostic significance of proliferative indices in meningiomas. J Neuropathol Exp Neurol 1994;53:247-55.
25. Burger PC, Shibata T, Kleihues P. The use of monoclonal antibody Ki-67 in the identification of proliferating cells. Am J Surg Pathol 1986;10:611-7.
26. Gattoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
27. Key G, Petersen JL, Becker MHG, et al. New anti-serum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections. J Clin Pathol 1993;46:1080-4.
28. Karamitopoulou E, Perentes E, Diamantis I, et al. KI-67 immunoactivity in human central nervous system tumors: a study with MIB-1 monoclonal antibody on archival material. Acta Neuropathol (Bern) 1994:87:47-54.
29. Ohta M, lwaki T, Kitamoto T, et al. MIB-1 staining index and scoring of histologic features in meningioma. Cancer 1994;74:3176-89.
30. Nakasu S, Nakasu Y, Nakajima M, et al. Potential doubling time and tumour doubling time in meningiomas and neurinomas. Acta Neurochir (Wien) 1996;138:763-70.
31. Perry A, Stafford S, Scheithauser B, et al. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 1998;82:2262-9.
32. Torp SH, Lindboe CF, Granli US, et al. Comparative investigation of proliferation markers and their prognosis relevance in human meningiomas. Clin Neuropathol 2001;20:190-5.
33. Rautiainen E, Haapasalo H, Sallinen P, et al. Histone mRNA in-situ hybridization in astrocytomas: a comparison with PCNA, MIB-1 and mitoses in paraffin-embedded materials. Histopathology 1998;32:43-50.
34. Holt PR, Moss SF, Kapetanakis AM, et al. Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen? Cancer Epidemiol Biomarkers Prev 1997;6:131-5.
35. Munakata S, Hendricks JB. Effects of fixation time and microwave oven heating time on retrieval of Ki-67 antigen from paraffin-embedded tissue. J Histochem Cytochem 1994;41:1241-6.
36. Onda K, Davis RL, Shibuya M, et al. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 1994;74:1921-6.